Evidence map›Paper›PMID 30242103›Full record

ArticleJournal of the American Society of Nephrology : JASN2018

Authors' Reply.

Julie H Ishida, Charles E McCulloch, Michael A Steinman, Barbara A Grimes, Kirsten L Johansen

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Julie H IshidaDepartments of Medicine and julie.ishida@ucsf.edu.
Charles E McCullochDivisions of Nephrology and.
Michael A SteinmanDepartments of Medicine and.
Barbara A GrimesDivisions of Nephrology and.
Kirsten L JohansenDepartments of Medicine and.ORCID /0000-0001-6421-361X

Funding

VARC CoreP30AG044281 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Louise C. Walter · 2013 to 2026
$19.9M
Institutional Career Development Core SupplementKL2TR001870 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANAYA, ALKA M., SARKAR, URMIMALA · 2016 to 2025
$19.7M
Clinical and Transtional Science InstituteKL2TR000143 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$11.9M
Prescribing cascades in older adults with and without dementiaK24AG049057 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEINMAN, MICHAEL A. · 2015 to 2025
$1.8M
Prevalence and Impact of Frailty among Dialysis PatientsK24DK085153 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHANSEN, KIRSTEN L. · 2010 to 2021
$1.5M
Facilitating Appropriate Analgesic Prescription in Hemodialysis PatientsK23DK103963 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ISHIDA, JULIE · 2015 to 2018
$621k
NCATS NIH HHS KL2 TR000143NCATS NIH HHS KL2 TR001870NIA NIH HHS K24 AG049057NIA NIH HHS P30 AG044281NIDDK NIH HHS K23 DK103963NIDDK NIH HHS K24 DK085153
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AminesGabapentinHumansPregabalinRenal DialysisAminesGabapentinPregabalingabapentinhemodialysispregabalinUnited States Renal Data System

Identifiers

PMID30242103
PMCPMC6218857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.